Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2026-02-02 @ 8:19 PM
Study NCT ID:
NCT01586195
Status:
TERMINATED
Last Update Posted:
2017-05-25
First Post:
2012-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Sponsor:
Genentech, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML27763
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None